hydroxyproline has been researched along with clodronic acid in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (72.09) | 18.7374 |
1990's | 11 (25.58) | 18.2507 |
2000's | 1 (2.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexandre, C; Bressot, C; Chapuy, MC; Edouard, C; Mathieu, L; Meunier, PJ; Trechsel, U; Vignon, C | 1 |
Black, HE; Capen, CC; Geho, WB; Nagode, LA; Re, R; Yarrington, JT | 1 |
Bandmann, U; Eriksson, M; Glas, U; Hansen, J; Pfeiffer, P; Rotstein, S; Söderqvist, J; Strid, S | 1 |
Beard, DJ; Beneton, M; Harris, S; Kanis, JA; Preston, CJ; Russell, RG | 1 |
Beneton, MN; Galloway, J; Harris, S; Kanis, JA; McCloskey, EV; Yates, AJ | 1 |
Atkins, RM; Beneton, MN; Gray, RE; Hamdy, NA; Kanis, JA; Percival, RC; Preston, CJ; Russell, RG; Urwin, GH; Yates, AJ | 1 |
Adami, S; Garavelli, S; Guarrera, G; Lo Cascio, V; Montesanti, F; Rosini, S; Salvagno, G | 1 |
Bijvoet, OL; Blanksma, HJ; Dahlinghaus-Nienhuys, PJ; Harinck, HI | 1 |
Ascari, E; Attardo-Parrinello, G; Crema, F; Fiorentini, ML; Merlini, G; Pavesi, F | 1 |
Gray, RE; Greaves, M; Hamdy, NA; Kanis, JA; McCloskey, EV; Neil, FE; Preston, FE; Urwin, GH; Yates, AJ | 1 |
Canfield, RE; Jacobs, TP; Siris, ES | 1 |
Brown, CB; Galloway, J; Gray, RE; Hamdy, NA; Kanis, JA; McCloskey, E; Rattenbury, JM | 1 |
Caberlotto, L; Conte, N; Di Virgilio, R; Roiter, I | 1 |
Douglas, DL; Duckworth, T; Kanis, JA; Prenton, MA; Preston, CJ; Preston, FE; Russell, RG; Woodhead, JS | 1 |
Daly, M; Harris, ST; Neer, RM; Petkau, AJ; Potts, JT; Segre, GV; Tully, GL | 1 |
Fleisch, HA; Gallagher, JA; Guenther, HL | 1 |
Briancon, D; Chapuy, MC; Charhon, S; Delmas, PD; Edouard, C; Meunier, PJ; Vignon, E | 1 |
Canfield, RE; Hyman, GA; Siris, ES | 1 |
Beard, DJ; Cameron, EC; Douglas, DL; Kanis, JA; Paterson, AD; Preston, FE; Russell, RG | 1 |
Kovitz, KL; Krane, IM; Krane, SM; Simon, LS; Wortman, PD | 1 |
Chapuy, MC; Charhon, SA; Meunier, PJ | 1 |
Chapuy, MC; Delmas, PD; Meunier, PJ | 1 |
Adami, S; Guarrera, G; Lo Cascio, V; Marini, G; Rosini, S; Salvagno, G; Spiazzi, G | 1 |
Baquiran, DC; Bilezikian, JP; Shane, E | 1 |
Baquiran, DC; Canfield, RE; Osserman, EF; Schlatterer, JP; Sherman, WH; Siris, ES | 1 |
Alexandre, C; Bressot, C; Chapuy, MC; Edouard, C; Mathieu, L; Meunier, PJ; Trechsel, U; Vignon, E | 1 |
Beard, DJ; Douglas, DL; Duckworth, T; Kanis, JA; Preston, C; Russell, RG; Smith, TW; Underwood, I; Woodhead, JS | 1 |
Bijvoet, OL; de Vries, E; Frijlink, WB; Jie, K; Meijer, CJ; Mulder, H; Reitsma, PH; te Velde, J; van der Linden, H; van der Wey, JP; van Paassen, HC | 1 |
Baquiran, DC; Bilezikian, JP; Canfield, RE; Jacobs, TP; Shane, E; Siris, ES | 1 |
Arlot, ME; Meunier, PJ | 1 |
Berard, E; Edouard, C; Goedert, G; Meunier, PJ; Minaire, P; Pilonchery, G | 1 |
Alexandre, C; Briancon, D; Chapuy, MC; Charhon, S; Delmas, PD; Edouard, C; Meunier, PJ; Vignon, E | 1 |
Goa, KL; Plosker, GL | 1 |
Kylmälä, T; Lindholm, TS; Seppänen, J; Tammela, TL | 1 |
Alfano, FS; Basini, G; Campanini, C; Fantuzzi, M; Gatti, C; Girasole, G; Passeri, M; Pedrazzoni, M | 1 |
Houghton, F; Huss, H; Kanis, JA; McCloskey, E; O'Rourke, N | 1 |
de la Piedra, C; Díaz Diego, EM | 1 |
Beneton, MN; Blomqvist, C; Elomaa, I; Kanis, JA; Taube, T | 1 |
Meunier, PJ; Vignot, E | 1 |
Coombes, GM; Kanis, JA; Khan, SA; McCloskey, EV; Nakatsuka, K; Orgee, J | 1 |
Coleman, RE; Eastell, R; Guo, CY; Purohit, OP; Vinholes, J | 1 |
Arnala, I; Heikkinen, JE; Laitinen, K; Selander, KS; Väänänen, HK | 1 |
Fini, M; Gnudi, S; Lisi, L; Malavolta, N | 1 |
1 review(s) available for hydroxyproline and clodronic acid
Article | Year |
---|---|
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Topics: Animals; Bone Neoplasms; Bone Resorption; Calcinosis; Clinical Trials as Topic; Clodronic Acid; Dose-Response Relationship, Drug; Half-Life; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Metabolic Clearance Rate; Neoplasms; Osteitis Deformans; Osteoporosis; Tissue Distribution | 1994 |
14 trial(s) available for hydroxyproline and clodronic acid
Article | Year |
---|---|
Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone | 1979 |
Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Bone Neoplasms; Breast Neoplasms; Calcium; Clodronic Acid; Double-Blind Method; Female; Fluid Therapy; Humans; Hydroxyproline; Hypercalcemia; Hypocalcemia; Infusions, Intravenous; Middle Aged; Placebos; Prospective Studies | 1992 |
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteitis Deformans; Pamidronate; Remission Induction; Time Factors | 1987 |
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Pain | 1987 |
Dichloromethylene diphosphonate action in hematologic and other malignancies.
Topics: Administration, Oral; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Leukemia, Lymphoid; Male; Multiple Myeloma; Neoplasms; Pain | 1987 |
Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma.
Topics: Biopsy; Bone and Bones; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Multiple Myeloma; Radiography; Skull | 1982 |
Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
Topics: Administration, Oral; Adult; Aged; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Hypercalcemia; Middle Aged; Osteoclasts | 1983 |
Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Cyclic AMP; Diphosphonates; Female; Humans; Hydroxyproline; Hyperparathyroidism; Male; Middle Aged; Phosphates | 1981 |
Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.
Topics: Adult; Aged; Bone and Bones; Bone Resorption; Calcium; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Double-Blind Method; Drug Evaluation; Female; Humans; Hydroxyproline; Male; Middle Aged; Multiple Myeloma; Osteoclasts; Time Factors | 1980 |
Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Female; Humans; Hydrocarbons, Chlorinated; Hydroxyproline; Male; Methylene Chloride; Paraplegia; Phosphates | 1981 |
Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Calcium; Clodronic Acid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteolysis; Patient Compliance | 1995 |
Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric study.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcitonin; Calcium; Cell Count; Clodronic Acid; Female; Humans; Hydroxyproline; Middle Aged; Osteoclasts | 1993 |
Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Peptides | 1997 |
Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss.
Topics: Absorptiometry, Photon; Bone Density; Calcitriol; Calcium; Clodronic Acid; Collagen; Collagen Type I; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Female; Femur Neck; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Procollagen; Prospective Studies | 1997 |
28 other study(ies) available for hydroxyproline and clodronic acid
Article | Year |
---|---|
Effect of dichloromethane diphosphonate on calcium homeostatic mechanisms in pregnant cows.
Topics: Animals; Calcium; Cattle; Clodronic Acid; Cyclic AMP; Diphosphonates; Duodenum; Edetic Acid; Female; Homeostasis; Hydroxyproline; Hypocalcemia; Intestinal Mucosa; Lactation; Parathyroid Glands; Parathyroid Hormone; Pregnancy; Pregnancy, Animal; Protein Binding; Thyroid Gland | 1977 |
Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Topics: Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hydroxyproline; Inclusion Bodies, Viral; Inosine; Inosine Pranobex; Osteitis Deformans | 1985 |
Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Organophosphonates; Paget Disease, Extramammary; Time Factors | 1987 |
Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Infusions, Parenteral; Osteitis Deformans; Recurrence | 1985 |
Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
Topics: Alendronate; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Drug Resistance; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans | 1986 |
Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Topics: Adult; Aged; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Kidney Tubules; Leukemia; Male; Middle Aged; Neoplasms | 1987 |
Clodronate in the medical management of hyperparathyroidism.
Topics: Administration, Oral; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Infusions, Intravenous | 1987 |
Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
Topics: Adult; Aged; Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Drug Evaluation; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Neoplasms; Time Factors | 1985 |
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Topics: Alkaline Phosphatase; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hypercalcemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans | 1980 |
Secondary hyperparathyroidism associated with dichloromethane diphosphonate treatment of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Diphosphonates; Edetic Acid; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Osteitis Deformans; Parathyroid Hormone | 1982 |
Rapid intracellular degradation of newly synthesized collagen by bone cells. Effect of dichloromethylenebisphosphonate.
Topics: Animals; Animals, Newborn; Bone and Bones; Carbon Radioisotopes; Clodronic Acid; Collagen; Diphosphonates; Hydroxyproline; Rats; Tritium | 1982 |
The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
Topics: Aged; Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Multiple Myeloma; Osteitis Deformans | 1983 |
Serum levels of type I and III procollagen fragments in Paget's disease of bone.
Topics: Antibody Specificity; Calcitonin; Clodronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Peptide Fragments; Procollagen; Radioimmunoassay; Time Factors | 1984 |
Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
Topics: Adult; Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Time Factors | 1983 |
Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Osteitis Deformans | 1984 |
Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).
Topics: Aged; Alkaline Phosphatase; Calcitonin; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Kinetics; Male; Middle Aged; Osteitis Deformans | 1984 |
Effects of disodium dichloromethylene diphosphonate (CL2MDP) on Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Time Factors | 1980 |
Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcium; Clodronic Acid; Creatinine; Diphosphonates; Humans; Hydroxyproline; Movement; Osteitis Deformans; Pain; Parathyroid Hormone; Phosphates | 1980 |
APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Lymphocyte Activation; Osteitis Deformans; Pamidronate; Phagocytes; Rats; Zinc | 1980 |
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Diarrhea; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Hypercalcemia; Hypocalcemia; Kidney Tubules; Male; Middle Aged; Necrosis | 1981 |
Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients.
Topics: Adult; Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Uric Acid | 1981 |
Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Osteitis Deformans; Parathyroid Hormone; Radionuclide Imaging; Vitamin D | 1982 |
The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Neoplasms; Bone Resorption; Clodronic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Pain Measurement; Palliative Care; Prostatic Neoplasms | 1994 |
Acute effects of bisphosphonates on new and traditional markers of bone resorption.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Alendronate; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Female; Humans; Hydroxyproline; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Osteoporosis; Peptides; Time Factors | 1995 |
Usefulness of biochemical markers of bone turnover in rats after clodronate administration.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Biomarkers; Bone Development; Bone Resorption; Clodronic Acid; Creatinine; Hydroxyproline; Male; Osteocalcin; Rats; Rats, Wistar; Tartrates | 1993 |
Therapeutic strategy in Paget's disease of bone.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone and Bones; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography; Risk Assessment; Skull | 1995 |
Duration of response with oral clodronate in Paget's disease of bone.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Analysis of Variance; Clodronic Acid; Drug Administration Schedule; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Regression Analysis; Remission Induction; Retreatment; Retrospective Studies | 1996 |
Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women.
Topics: Aged; Analgesics, Non-Narcotic; Bone Density; Calcium; Clodronic Acid; Female; Femur Neck; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intramuscular; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphates | 2001 |